News

Press Releases

02/08/17
BioRestorative Therapies Receives FDA Clearance to Initiate Phase 2 Clinical Trial for the Treatment of Patients with Degenerative Disc Disease
01/09/17
BioRestorative Therapies Submits IND Application to FDA to Treat Patients with Degenerative Disc Disease
09/12/16
BioRestorative Therapies Announces Publication in Medical Journal of Positive Results of Long-Term Safety and Feasibility Study Using Cell Therapy to Treat Patients with Degenerative Disc Disease
07/13/16
BioRestorative Therapies Announces Presentation at 3rd Annual Regenerative Medicine Essentials Course
06/28/16
BioRestorative Therapies Announces Completion of Human Safety and Feasibility Study on the Use of Hypoxic Cultured Stem Cells to Treat Chronic Lower Back Pain
BioRestorative Therapies: A Stem Cell Biotechnology Company